• AAPL 169.89
  • TSLA 170.18
  • AMZN 173.67
  • MSFT 399.04
  • INTC 35.11
  • EURUSD 1.0727
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NYSE /
  3. ADCT.NYSE

ADC Therapeutics SA (ADCT NYSE) stock market data APIs

$4.65 0.21(4.7%) as of April 25, 2024

ADC Therapeutics SA Financial Data Overview

4.44
4.65
-
4.65
4.41
0.3599-6.04
394 M
82 530 K
69 558 K
-1.03
1.74
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ADCT',
Type: 'Common Stock',
Name: 'ADC Therapeutics SA',
Exchange: 'NYSE',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: 'CH0499880968',
CUSIP: '',
CIK: '61478',
EmployerIdNumber: '41-0743912',
FiscalYearEnd: 'September',
IPODate: '1979-03-16',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

ADC Therapeutics SA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 69 558 K
  • EBITDA -164 799 008
  • Earnings Per Share -2.94
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get ADC Therapeutics SA Earnings via APIs

  • Latest Release 2024-03-13
  • EPS/Forecast -0.5

Get ADC Therapeutics SA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get ADC Therapeutics SA latest news via APIs

15 Top Performing European Stocks So Far in 2024

In this piece, we will take a look at the 15 top performing European stocks so far in 2024. If you want to skip our overview of the European economy and the stock climate, then you can skip ahead to 5...

The 3 Biotech Stocks That Could Make Your February Unforgettable

Following a hot year of M&A with biotech stocks, we’ll see more of the same in 2024 as drug makers look to build their pipelines ahead of a massive patent cliff. Between now and 2028, pharmaceutica...
Do you have any questions?
support@eodhistoricaldata.com